Current topics in the treatment of prostate cancer with low-dose-rate brachytherapy.
The treatment of prostate cancer with low dose rate prostate brachytherapy has grown rapidly in the last 20 years. Outcome analyses performed in this period have enriched understanding of this modality. This article focuses on the development of a real-time ultrasound-guided implant technique, the importance of radiation dose, trimodality treatment of high-risk disease, long-term treatment outcomes, and treatment-associated morbidity.
Department of Radiation Oncology, Mount Sinai School of Medicine, Mount Sinai Hospital, 1184 5th Avenue, New York, NY 10029, USA. Richard.Stock@mountsinai.org
Richard G
RG
Stock
Nelson N
NN
Stone
D001918:Brachytherapy / Q000401:mortality*; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011829:Radiation Dosage; D012307:Risk Factors; D016896:Treatment Outcome